Cow Colostrum Regresses STAM-induced Non-alcoholic Steatohepatitis-associated Hepatocellular Carcinoma in Mice

Nutraceuticals is an emerging industry with the potential to cater the needs of many therapeutic domains, including cancer a major cause of health concerns. Despite the currently available therapeutics, complication and effective medical management of HCC, particularly at an advanced stage has several limitations. Hence, in the present study an alternative approach using an animal product cow colostrum as therapeutics for HCC is explored in STAM-induced non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice. If successful this might prove to be a very viable and effective management for NASH-associated HCC.